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Stimulation of Maxi-K Channels in Trabecular
Meshwork by Tyrosine Kinase Inhibitors
Friederike Stumpff, Yang Que, Marianne Boxberger, Olaf Strauss, and Michael Wiederholt
PURPOSE. Muscarinic agonists contract and tyrosine kinase inhibitors relax precontracted trabecular
meshwork, a smooth muscle-like tissue involved in the regulation of aqueous humor outflow. The
effect of tyrosine kinase inhibitors on membrane currents of cells stimulated by acetylcholine was
examined.
METHODS. Cells from bovine trabecular meshwork were studied using both the perforated patch-
clamp technique with nystatin and the single-channel technique.
RESULTS. Application of the tyrosine kinase inhibitor genistein (5 X 10~5 M) on trabecular
meshwork cells stimulated with acetylcholine resulted in a reversible increase in outward current
to 578% ± 154% (n = 16) of the initial current level. The effect of genistein was dose dependent.
Reversal potential was hyperpolarized by 15 ± 3 mV (n = 9). Tyrphostin 51, a synthetic inhibitor
of tyrosine kinases, had the same effect (433% ± 46%; n = 7). Daidzein, a nonactive structural
analogue of genistein, had no effect (n — 4). The stimulation of outward current by tyrosine kinase
inhibitors was blocked by substitution of tetraethylammonium (TEA+) for potassium, whereas the
potassium channel blockers glibenclamide (K-ATP) and apamin (low-conductance calcium-acti-
vated potassium channel) had no effect. Blockage of the high-conductance calcium-activated
potassium channel (maxi-K) by charybdotoxin or iberiotoxin (10~7 M) suppressed 86% ± 18% (n =
4) of the response. Depleting the cells of calcium did not have an effect on the current stimulated
by genistein. In the excised inside-out configuration, open probability increased to 417% ± 39%
(n = 3) after exposure to genistein.
CONCLUSIONS. In trabecular meshwork, tyrosine kinase inhibitors activate maxi-K (KCa) channels.
Hyperpolarization caused by efflux of potassium could lead to the relaxation of trabecular mesh-
work by tyrosine kinase inhibitors. (Invest Ophthalmol Vis Sci. 1999;40:l404-l4l7)
In recent years, increasing attention has been paid to theactive contribution of trabecular meshwork in regulatingaqueous humor outflow and thus intraocular pressure.1
Located in the ocular outflow pathway between the anterior
chamber and Schlemm's canal, this tissue is not merely pas-
sively distended by the ciliary muscle but exhibits active con-
tractile properties of its own with an impact on outflow resis-
tance.2'3 In this study, we investigated the effect of tyrosine
kinase inhibitors on the membrane currents of trabecular
meshwork cells, measured by the patch-clamp technique.
Tyrosine kinase inhibitors are a group of substances of
increasing interest as new therapeutic agents for a variety of
diseases such as cancer, psoriasis, atherosclerosis, and septic
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shock.4 7 In a previous study, we showed that tyrosine kinase
inhibitors relax precontracted strips of trabecular meshwork.8
Interestingly, strips of ciliary muscle were not relaxed to the
same extent. Thus, tyrosine kinase inhibitors seem to be prom-
ising candidates for the treatment of glaucoma. Ideally, they
should lead to the reduction of intraocular pressure (through
relaxation of the trabecular meshwork3'8) while simulta-
neously improving retinal circulation (through vasodila-
tion910). However, much more research is needed to validate
these hypotheses.
Apart from their therapeutic potential, tyrosine kinase
inhibitors are also intriguing tools for the study of signal trans-
duction pathways.6'' To date, most of the research investigat-
ing the physiological role of tyrosine kinases has revolved
around their participation in the regulation of mitogenesis and
cell migration.12 By comparison, interest in tyrosine kinases as
mediators of smooth muscle contractility is fairly recent.1013
Thus, receptor tyrosine kinases such as the receptor for epi-
dermal growth factor (EGF) have an influence on smooth
muscle contractility. In addition, tyrosine kinase inhibitors
have been shown to suppress the contractile response of
visceral and vascular smooth muscle after stimulation by agents
such as acetylcholine.1013 It appears that receptor-mediated
responses of smooth muscle cells involve the phosphorylation
of proteins on tyrosine residues and that this induces both the
release of Ca2+ from the sarcoplasmic reticulum, and influx of
Ca2+ from the outside of the cell. Very little is known about the
nature of the proteins that are phosphorylated. However, evi-
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dence is emerging that various ionic channels are among the
targets of tyrosine kinases.9'10'14"16
Using the perforated-patch and single-channel configura-
tions of the patch-clamp technique, we were able to show that
tyrosine kinase inhibitors enhance outward current of trabec-
ular meshwork cells in a dose-dependent manner, and that this
effect is directly mediated by high-conductance calcium-acti-
vated potassium channels (maxi-K channels, BKC;|). Interest-
ingly, the stimulation is not caused by the calcium- and voltage-




All experiments were performed in compliance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. Primary bovine trabecular meshwork cell cultures
were prepared as described previously.17"20 In summary,
freshly enucleated bovine eyes were obtained from a local
abattoir. Small pieces of trabecular meshwork were obtained
from the eyes, placed in a sterile petri dish under a glass
coverslip, and fed twice weekly with Dulbecco's modified
Eagle's minimum essential medium (DMEM) supplemented
with 100 U/ml penicillin, 100 jug/ml streptomycin, and 10%
fetal calf serum (all cell culture material from Biochrom, Berlin,
Germany). Cultures were maintained in a 95% air/5% CO2
atmosphere at 37°C. The cultures were passaged using the
trypsin-EDTA method. Only cells from the third passage were
used for experiments.
Patch-Clamp Experiments
All experiments were performed essentially as in a previous
study.21 Nystatin (150 /xg/ml) in the patch pipette was used to
obtain perforated patches.22 To obtain single cells from con-
fluent cell layers, cells were dispersed by enzymatic treatment
with trypsin for 3 minutes. Subsequently, trypsin was inacti-
vated by resuspension in calcium-containing cell culture me-
dium, and cells were allowed to settle on glass coverslips for
half an hour at 37°C. The coverslips were then introduced into
a perfusion chamber on the stage of an inverted microscope
(Axiovert 35; Zeiss, Oberkochen, Germany) and were super-
fused with Ringer's solution. The chamber itself was heated
(LN Temperature Controller, Ratingen, Germany) and the per-
fusate prewarmed. All experiments were performed at 37°C.
Fluid exchange was complete within less than 5 seconds.
Borosilicate glass patch pipettes (wall thickness, 0.3 mm; Clark
Electromedical Instruments, Reading, UK) were pulled and
polished using a DMZ Universal Puller (Zeitz, Augsburg, Ger-
many). The input resistance of the pipettes filled with the
standard intracellular solution (see later description) was 3 Mil
to 4 MCI. Potentials were referenced to the bath using an
Ag-AgCl electrode connected to the bath solution by an agar
bridge electrode so that a negative potential corresponded to a
negative pipette potential. Liquid junction potentials were de-
termined and corrected according to the method described by
Neher.23 Unless indicated otherwise, positive ions flowing into
the pipette correspond to a negative current and are depicted
in figures as going downward, whereas positive ions flowing
out of the pipette are designated by a positive current in the
upward direction. For inside-out patches, the pipette poten-
tial corresponds to the negative membrane potential.
As in previous contractility measurements,8 cells were
superfused with Ringer's solution containing acetylcholine
(5 X 10~5 M) before seal formation and throughout the entire
recording. Care was taken to ensure stabilization of currents
before application of substances.
Data Acquisition
Currents were recorded using an EPC 9 patch-clamp amplifier
(HEKA Elektronic, Lambrecht, Germany). Pulse generation,
data collection, and analysis were performed using by com-
puter software (TIDA for Windows; HEKA) and filtered with a
2.9-kHz Bessel filter. Records were corrected for capacitance.
Whole-cell measurements were not leak subtracted, because it
was difficult to distinguish between a nonspecific leak and a
physiological non-voltage-dependent current. According to
TIDA software, access resistance was below 8 Mil and auto-
matically corrected. Several types of pulse protocols were
used.21 In whole-cell experiments, two types of protocols
were used. Changes in external solution were monitored using
a protocol that generated steps of 200-msec duration to various
voltages between —80 mV and 100 mV. After each step, die
voltage returned to a holding potential of —40 mV for 200
msec. Currents were continuously sampled at 100 Hz through-
out the duration of the protocol (see Fig. IB; the sequence
depicted was repeated hundreds of times to produce the trace
seen in Fig. 1C). After completion of the solution changes and
a stabilization of current levels, a second, conventional pulse
protocol was used to record currents. In this protocol, data
were first acquired at the holding potential for 20 msec, then
the potential was stepped to a value between —80 mV and 100
mV for 50 msec, followed by a 30-msec return to the holding
potential. Throughout this recording, data were sampled at 5
kHz. For single-channel experiments, voltage was also automat-
ically stepped to various levels. Data acquisition started 0.5
seconds after the voltage step at a sampling rate of 10 kHz for
a duration of 6 seconds before the next voltage step took place.
Solutions and Chemicals
Control Ringer's solution contained the following ion concen-
trations (in millimolar): 151 NaCl, 4 KC1, 1.7 CaCl2, 1 KH2PO4,
0.9 MgSO4, 10 HEPES, and 5 glucose adjusted to pH 7.4
(NaOH). The standard intracellular solution (pipette solution)
for whole-cell experiments contained (in millimolar) 119 K-
glutamate, 10 NaCl, 1 KH2PO4, 0.9 MgSO,,, 33 EGTA, 6.6
CaEGTA, and 10 HEPES adjusted to pH 7.2 (NaOH). This
solution corresponded to an internal calcium concentration of
2.7 X 10~7 M2" and was referred to as the high-potassium
solution. For substitution of potassium in the pipette solution,
an equimolar amount of tetraethylammonium hydroxide
(TEAOH) was titrated with gluconic acid. For single-channel
experiments, the standard bath solution contained (in millimo-
lar) 134 KC1, 11 NaCl, 1 KH2PO4, 0.9 MgCl2, and 10 HEPES
adjusted to pH 7.4 (NaOH). Calcium was buffered to 10~7 M
using EGTA and, for some experiments, to 10~5 M using ni-
trilotriacetic acid according to established procedures.25 The
pipette solution for single-channel experiments was the same
in principle, but potassium concentration was lowered to 50
mM, sodium was raised to 95 mM, and calcium was raised to 1
mM. All chemicals were of the highest available grade of purity.
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FIGURE 1. (A) Standard patch-clamp configuration with nystatin, using a high-potassium intracellular solution. (B) Standard voltage-pulse
protocol. The sequence depicted was repeated hundreds of times to produce the trace seen in (C). (C) Typical recording of a single cell. A strong
outward current could be measured, which was reversibly enhanced by genistein (5 X 10~5 M). (D) Summary of results from 16 experiments. **P <
0.005.
Charybdotoxin (ChTX) and iberiotoxin (IbTX) were obtained
from Bachem (Heidelberg, Germany) and were dissolved in
phosphate-buffered saline (PBS) before addition to the solu-
tion. Tetraethylammonium chloride (TEAC1) and TEAOH were
from Sigma (Deisenhofen, Germany). Genistein was from Re-
search Biochemical (Cologne, Germany), and tyrphostin 51
and daidzein were from Sigma.
Analysis
In the following, "outward current" refers to current values
obtained from pulse protocols as depicted in Figure IB and at
a pipette potential of 80 mV. Because outward current varied
greatly from cell to cell, the current level at the beginning of
the experiment was taken as 100% and will be referred to as
"initial outward current." All changes in outward current were
seen in relation to this initial value. All current values were
obtained immediately before the subsequent change of solu-
tion; in case of recovery, immediately before the end of the
experiment (usually caused by rupture of the seal). The
changes (in percent) were used to calculate mean values ±
SEM. Significance testing was performed using the paired Stu-
dent's t-test and standard software (Sigma Plot Scientific Graph
System, ver. 1.02; Jandel, Corte Madera, CA). N refers to the
number of experiments. Each experiment was performed us-
ing one cell. Cells were derived from different explants.
In single-channel experiments, channel conductance was
determined by fitting current-voltage relationships using the
Goldman-Hodgkin-Katz equation. All fits were performed us-
ing commercially available software (Sigma Plot Scientific
Graph System, Jandel). Because it was not possible to deter-
mine the exact number of channels per patch, channel activity
was estimated from the product NPO, where N is the number of
channels and Po is single-channel open probability. The time
integral of current divided by the product of mean single-
channel current and time of recording is equal to NPo.2(i
RESULTS
Stimulation of Outward Current by Tyrosine
Kinase Inhibitors
After seal formation and formation of the perforated-patch
configuration with nystatin, cells were superfused with a con-
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FIGURE 2. Dose dependence of the effect of genistein. (A) Summary of nine experiments. Initial outward current at 80 mV was taken as 100%.
*P < 0.05; **P < 0.005. (B) Individual trace.
trol solution (Ringer's) until current levels had stabilized. For
comparison with experiments on trabecular meshwork strips
precontracted by muscarinic agonists,2'27 acetylcholine (5 X
10 M) was routinely added to the external solution in the
patch-clamp experiments.
Application of the tyrosine kinase inhibitor genistein in a
dose of 5 X 10~5 M resulted in a strong, sustained increase in
outward current. Degree of stimulation varied greatly among
individual cells, but some degree of stimulation could be ob-
served in each cell, yielding an average stimulation of outward
FIGURE 3. In nine cells tested, application
of genistein (5 X 10~5 M) significantly low-
ered reversal potential by 5 ± 3 mV (n = 9).














































FIGURE 4. (A) Standard patch-clamp configuration. (B) Standard voltage-pulse protocol. (C) Outward current was enhanced by tyrphostin 51 (5 X
10~5 M). (D) Summary of results from seven experiments **P < 0.005.
current at 80 mV to 495% ± 83% of the initial level (n = 16;
P < 0005; Figs. 1C, ID). After withdrawal of genistein, recov-
ery occurred to a level of 264% ± 43% (P < 0.05) as measured
at the end of the experiment. Usually, seals ruptured at this
point, so that recovery was incomplete because of incomplete
washout. When seals remained stable, recover)' was usually
complete (compare Fig. ID). In another series of experiments
on nine individual cells, different concentrations of genistein
were applied to the same cell in succession, showing that the
effect was dose dependent. (Fig. 2).
In a second step, we determined membrane potential as
the potential at which membrane current equals zero (reversal
potential). After seal formation, this value was similar to values
obtained by conventional membrane voltage measurements
and to values reported in an earlier patch-clamp study (42 ± 4
mV; n = 22).21 As membrane current stabilized, this value
increased to higher levels, perhaps as a result of the diffusion
of ionic constituents out of the patch pipette into the cell and
vice versa. Genistein reversibly hyperpolarized this value by
15 ± 3 mV in = 9; P < 0.005; Fig. 3).
To assess if this effect was attributable to nonspecific
actions of genistein, we applied tyrphostin 51, a tyrosine ki-
nase inhibitor with a different mode of action7 and a relatively
high specificity for the EGF receptor. In these experiments, a
similar elevation of outward current could be evoked (433% ±
46%; n = 7), with recovery to 259% ± 13% (Fig. 4). When
genistein and tyrphostin 51 (both in a concentration of 5 X
10 M) were applied to the same cell in succession, no signif-
icant differences could be observed. Apparently, the stimula-
tion of outward current was not dependent on the type of
tyrosine kinase inhibitor used (n — 4). In contrast, daidzein
(5 X 10~5 M), an inactive structural analogue of genistein,7 had
no effect (n = 4; Fig. 5).
Identification of the Current Stimulated by
Tyrosine Kinase Inhibition
To find ovit which channels were involved in the response of
trabecular meshwork cells to genistein, we used the unspe-
cific, but potent blocker of potassium channels TEAC1 (5 mM;
Fig. 6), which blocked the induction of current by genistein
completely (more than 99%; n = 5). In a second series of
experiments, TEAC1 was substituted for KC1 was substituted in
the external solution and TEA-gluconate for K-glutamate in the
pipette solution. Outward current level was greatly reduced
from 0.5 ± 0.1 nA (n = 9) in solutions containing potassium to
0.05 ± 0.01 nA (n = 4) in potassium-free solutions. In four
cells tested in the absence of potassium, genistein (5 X 10~5
M) evoked no significant changes in inward or outward cur-




FIGURE 5. In four cells tested, daidzein (5 X 10~5 M) did not induce a significant increase in outward current. (A) Summary of four experiments.
(B) Individual experiment.
rent. Thus, the genistein-induced current was caused by an
outflow of potassium, excluding participation of other ions
such as chloride. In subsequent experiments, various potas-
sium channel blockers were tested. For this purpose, outward
current was measured in control solution (Ringer's). Then, the
blocker was added to assess the contribution of the channel in
question to the outward current of the resting cell. Subse-
quently, genistein (or tyrphostin 51) was added in the presence
of the blocker. Withdrawal of the blocker in the presence of
genistein was followed by a return to the control solution. This
made it possible to determine the genistein-induced increases
in outward current in the presence and absence of the blocker
and to determine the relative difference between them using
data obtained from one cell. Glibenclamide (10~5 M), which
blocks ATP-dependent potassium channels (K-ATP) had no
significant effect, either on resting current or on the current
enhanced by genistein. This was not dependent on whether
glibenclamide was applied before genistein (n = 4) or after-
ward in = 7; Fig. 7). Apamin (10~6 M), a blocker of the
low-conductance calcium-dependent potassium channel (SK),
also did not block the genistein-induced increase in outward
current (Fig. 8), regardless of whether it was applied before
(n = 4) or after (n = 3) genistein. Because trabecular mesh-
work cells express maxi-K channels,21 we tried blocking these
channels with the specific blockers IbTX (10~7 M; Fig. 9) and
ChTX (10~7 M; Fig. 10). Both blockers reduced resting out-
ward current. Whereas IbTX blocked resting outward current
to 22% ± 6% (n = 4;P < 0.001) of the initial level at 80 mV,
ChTX blocked it to 71% ± 16% (n = 4; P < 0.001), reflecting
the greater potency of IbTX for blocking this channel.28 Both
agents significantly blocked the major part of the genistein-
induced increase in outward current in all cells tested. In the
presence of ChTX, the response to genistein was only 38% ±
6% (n = 4; P < 0.05) of the response observed in the absence
of ChTX. Iberiotoxin reduced the response to genistein to 22%
± 5% (n = 4; P < 0.05) of the response in the absence of this
blocker (Fig. 9). When the order of application was reversed
and genistein was applied before IbTX, IbTX reduced the
response to 9% ± 3% in = 4; P < 0.05). The order in which the
substances were applied did not have a significant effect on the
outcome of the experiment. The outward current enhanced by
tyrphostin 51 was also sensitive to blockage of the maxi-K
channel. In the presence of ChTX, the response was 47% ±
14% in = 4; P < 0.05) of the unblocked response 0<ig. 10),
while in the presence of IbTX, only 12.78% ± 2% (n = 6; P <
0.001) of the response remained.
Variation of Cytosolic Calcium on Genistein-
induced Outward Current
To assess a possible contribution of calcium to this response,
cells were preincubated in calcium-free solution containing 10
mM EGTA to prevent influx of intracellular calcium from the
extracellular space. To prevent influx of calcium from cytoso-
lic stores, they were depleted by a thapsigargin pulse (10~6 M)






FIGURE 6. In five cells tested, TEAC1 (5 mM) completely suppressed the response to genistein (5 X 1CT5 M). (A) Summary of five experiments.
(B) Individual experiment.
of 400 seconds' duration.29 Under these conditions, applica-
tion of genistein (5 X 10~5 M) in a calcium-free solution had
the same effect as in a solution with normal calcium. Reappli-
cation of calcium in the continued presence of genistein had
no effect on outward current (Fig. 11).
Single-Channel Recordings
Next, we investigated the effect of genistein on channels in the
excised inside-out configuration of the patch-clamp tech-
nique. In inside-out patches, we observed the same 300-pS
channel described previously.21 We verified the identity of this
channel as a maxi-K channel by stimulating it with CaCl2 (10~5
M) and observing the reversal potential in asymmetrical potas-
sium chloride solution. When genistein (10~4 M) was added to
the cytosolic side of the patch, the open probability of the
channel increased by 417% ± 39% (n = 3; P < 0.05; Fig. 12).
DISCUSSION
Using a preparation of bovine trabecular meshwork cells, we
were able to show that the application of the tyrosine kinase
inhibitors genistein and tyrphostin 51 stimulated an outward
current through activation of maxi-K channels previously char-
acterized.21 Stimulation could also be observed in excised
patches and therefore seems to be the result of a signaling
cascade involving only membrane-bound components. In par-
ticular, it was not a result of changing levels of cytosolic
calcium. Hyperpolarization caused by activation of maxi-K
channels seems to be one of the underlying effects explaining
the previously described relaxation of trabecular meshwork
strips in response to the application of tyrosine kinase inhibi-
tors.8
The stimulation of current by genistein was dose depen-
dent in a range typical of other cell types and ionic chan-
nels.9'15'30"34 This range of concentration corresponds to the
range in which relaxation of smooth muscle in general13 and
relaxation of trabecular meshwork in particular8 has been
observed.
The bovine model is a well-established experimental
model.1"3'17"19'2735"38 Unlike human eyes, bovine eyes allow
macroscopic separation of trabecular meshwork and ciliary
muscle, making it possible to measure directly the tonus of
trabecular meshwork and to show that this tissue contracts and
relaxes similarly to smooth muscle cells in response to various
substances.8'2738'39 Other groups have shown that agents that
induce contraction elevate cytosolic calcium.18'40"''2 In addi-
tion, both human and bovine trabecular meshwork cells ex-
press smooth muscle a-actin and myosin.43'44 Although the
mechanism resulting in contraction remains unknown,45'46
functionally, trabecular meshwork cells contract and relax sim-
ilarly to smooth muscle cells in response to changes in cyto-
solic calcium. In another study on the regulation of outflow
rate, we were able to show that relaxation of trabecular mesh-
work is associated with an enhancement of outflow and con-
traction with a reduction in outflow facility.3 Substances that
relax trabecular meshwork more strongly than ciliary muscle
may therefore have a beneficial impact on intraocular pressure.
Tyrosine kinase inhibitors have that property.8










































FIGURE 7. Glibenclamide (10~5 M), a blocker of ATP-dependent potassium channels, had no significant effect on the induction of current by





FIGURE 8. Apamin (10~6 M), which blocks low-conductance calcium-activated potassium channels, had no effect on the induction of outward
current by genistein (5 X 10~5 M). (A) Summary of four experiments. Initial outward current at 80 mV was taken as 100%. **P < 0.005. (B)
Individual experiment.
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FIGURE 9. Iberiotoxin (10~7 M), a specific blocker of high-conductance calcium-activated potassium channels (maxi-K), blocked the major part




FIGURE 10. Charybdotoxin (10 7 M), another blocker of maxi-K channels, blocked the major part of the current induced by tyrphostin 51 (5 X
10~5 M). (A) Summary of four experiments. Initial outward current at 80 mV was taken as 100%. *P < 0.05. (B) Individual experiment.















FIGURE 11. The effect of genistein on outward current level in cells depleted of calcium by thapsigargin (10~6 M) in a calcium-free solution
buffered with 10 mM EGTA. (A) Summary of four experiments. Initial outward current at 80 mV was taken as 100%. Nonsignificant: P > 0.1. (B)
Individual experiment.
Tyrosine kinase inhibitors are a group of substances
whose therapeutic potential for a number of diseases is cur-
rently emerging.' 6 A vast number of compounds exist with
variable specificity for various cellular tyrosine kinases. We
were able to show a relaxation of trabecular meshwork in
response to genistein and tyrphostin 5 1 8 Although genistein
reportedly blocks a number of tyrosine kinases and is thus an
excellent scanning tool in searching for a tyrosine kinase-
dependent mechanism, tyrphostin 51 shows an affinity for the
EGF receptor tyrosine kinase.8'47 Because daidzein, a nonactive
structural analogue, showed no effect, it is safe to assume that
the stimulation of the channel by genistein and tyrphostin is
caused by a specific inhibition of tyrosine phosphorylation,
although some caution should be used in interpreting the exact
nature of the tyrosine kinase involved. More research is needed
before it is safe to say that the EGF receptor affects the maxi-K
channel, particularly because in other preparations of smooth
muscle, the membrane-bound tyrosine kinase pp60csrc seems
to be involved in mediating contraction.13
Recent reports link tyrosine kinases to the relaxation and
contraction of visceral and vascular smooth muscle.13'48 Re-
ceptor-mediated contraction has been shown to involve the
phosphorylation of various proteins on tyrosine residues.
These include rasGAP and PLCy13'49; many others have yet to
be identified. One of the effects of receptor-activated tyrosine
phosphorylation in smooth muscle is an increase both in cal-
cium influx from the outside and in calcium release from the
stores.'3
Although most research has centered on the alteration of
cytosolic proteins by tyrosine kinases, the regulation of mem-
brane proteins by protein tyrosine kinases has also been stud-
ied to some extent. Using preparations from various tissues,
the increase in the open probability of L-type calcium channels
by tyrosine phosphorylation has been reported by a number of
investigators."14,30,32,50 In contrast, there is only scant informa-
tion on the regulation of other ionic channels by tyrosine
phosphorylation. Thus, Chiang et al.50 report the inhibition of
cAMP-dependent chloride channels, and Minami et al.51 report
activation of nonselective cation channels by genistein. The
reports on potassium channels differ. Reports on vascular
smooth muscle include stimulation9'52 and suppression31 of
potassium channels by tyrosine phosphorylation. The same
confusing situation can be found with cardiomyocytes, in
which both stimulation53 and suppression54'55 are also re-
ported. Experimental protocols used in these studies varied,
and more studies are needed before a serious attempt can be
made to compare and interpret the data.
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FIGURE 12. The effect of genistein on the open probability of maxi-K channels in the inside-out configuration. (A) Schematic representation of
the inside-out patch-clamp configuration. (B) Traces from one patch showing stimulation of open probability by genistein. (C) Summary of the
results of three experiments. Similar to preparations with an intact cytosolic compartment, genistein stimulated maxi-K channels. *P < 0.05.
To our knowledge, only two studies exist concerning the
tyrosine kinase sensitivity of maxi-K channels. In Chinese ham-
ster ovary cells, Prevarskaya et al.15 report an inhibition of the
channel by tyrosine kinase inhibitors, whereas Xiong et al.31
report the opposite effect using a preparation of rat aortic cells.
In a previous study, we were able to show the presence of
maxi-K channels in bovine trabecular meshwork.2' The impor-
tant role of maxi-K channels (high-conductance calcium-acti-
vated potassium channels, BKC:|) in smooth muscle cells is
undisputed.56'57 An important function is to hyperpolarize
cells after cytosolic calcium increases, thus serving as a mech-
anism for negative feedback. One of the paradoxes is how high
calcium levels have to be before significant stimulation of
maxi-K channels can be observed. Although carbachol (10~4
M) and endothelin (10~8 M) are reported to increase cytosolic
calcium to levels of 300 nM to 500 nM in trabecular mesh-
work,18'40'41 cytosolic calcium has to exceed 10~5 M before an
appreciable enhancement of open probability in the inside-
out configuration can be observed.21 Under physiological con-
ditions, in the presence of cytosolic components such as spe-
cific enzymes or ATP, this level may well be lower. In addition,
submembranous compartments have been shown to have cal-
cium levels sufficient to stimulate associated maxi-K chan-
nels.56 Nevertheless, the disparity between calcium levels
physiologically observed in the main compartment of cells and
the levels needed to stimulate maxi-K channels is disturbing.
In this article, we present a new model for the regulation
of maxi-K channels in trabecular meshwork (Fig. 13) that
involves tyrosine phosphorylation, iinrelated to the stimulation
by elevating cytosolic calcium. The action of genistein on
channels in the inside- out configuration speaks for a relatively
direct signaling cascade involving membrane-bound constitu-
ents. Possibly, the open probability of maxi-K channels is
modulated by direct phosphorylation of the channel protein on
a tyrosine residue by a tyrosine kinase. Membrane-bound ty-
rosine kinases have been found in the membranes of various
cellular preparations, including membrane receptor tyrosine
kinases (such as the EGF receptor) and membrane-associated
nonreceptor tyrosine kinases related to pp60c'src.13 Holmes et
al.58 report an association of a tyrosine kinase with a potassium
channel. Interestingly, voltage-dependent potassium channels
from the Shaker family are reported to have a tyrosine kinase
site on the inactivating N-terminal.59 Possibly, maxi-K chan-
nels, which have the same basic structure with six membrane-
spanning domains and the same voltage sensor,60 share this
feature. Although extensive literature exists on the regulation
of maxi-K channels by calcium or voltage,21'56'60 we believe
that the regulation by tyrosine phosphorylation may be an
important additional feature that explains the physiological
role of these channels.
The way in which potassium channels affect smooth mus-
cle tone has been amply described.61'62 In smooth muscle
cells,62'63 but also in many nonmuscle cells,64 calcium is
known to activate contractile proteins through a cascade in-
volving the binding of calcium to calmodulin which in turn
activates myosin light-chain kinase. Myosin light-chain kinase,
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FIGURE 13. Schematic model of the
function of maxi-K channels in me-
diating relaxation of trabecular
meshwork cells by tyrosine kinase
inhibitors. Inhibition of tyrosine ki-
nase leads to an increase in the open
probability of maxi-K channels. This
leads to hyperpolarization, which in
turn closes L-type channels and de-
creases the release of calcium from
cytosolic stores. Both effects lower
cytosolic calcium leading to relax-
ation. Lower levels of cytosolic cal-
cium also tend to shut down the

















in turn, phosphorylates myosin, enabling it to attach to actin,
generating force. Conversely, a decline in cytosolic calcium
leads to relaxation. Considering that trabecular meshwork cells
contain smooth muscle a-actin and smooth muscle myo-
sin,43'44'6566 it is not unreasonable to assume that trabecular
meshwork contractility is also regulated in this way. In previ-
ous studies, application of muscarinergic agonists to trabecular
meshwork cells led to depolarization37 and to an increase in
cytosolic calcium.4' Possibly, this induces a latching of actin
and myosin leading to contraction, as observed in contractility
experiments.27 In contractility experiments, application of ty-
rosine kinase inhibitors to trabecular meshwork strips precon-
tracted by carbachol led to relaxation.8 The data presented
here suggest that this relaxation is caused by an opening of
maxi-K channels with subsequent efflux of potassium, leading
to hyperpolarization (Fig. 13). This, in turn, leads to a closure
of L-type calcium channels18 and to a decrease in calcium
efflux from cytosolic calcium stores through ryanodine-sensi-
tive channels56'67'68 and a stimulation of calcium efflux
through the sodium-calcium exchanger.49 All these mecha-
nisms should lead to a decline in cytosolic calcium and to
relaxation through uncoupling of actin and myosin.
In addition to the pathway outlined above, many smooth
muscle cells also exhibit a calcium-independent mechanism of
contraction.69'70 Data from previous studies46'71 suggest that
trabecular meshwork, too, possesses one or more pathways of
this type.
For better comparability with the contraction experi-
ments,8 all data presented here were recorded using bovine
trabecular meshwork cells. Preliminary results from a study we
are currently engaged in show that human trabecular mesh-
work cells react in the same way. Future work should show the
link of maxi-K channel activation to a decrease in cytosolic
calcium by directly measuring intracellular calcium.
In summary, we present evidence for the relaxation of
trabecular meshwork by tyrosine kinase- dependent activation
of maxi-K channels. Tyrosine kinase inhibitors, with their po-
tential for relaxing both vascular smooth muscle1013 and tra-
becular meshwork8 seem to be promising new candidates in
the search for a more effective therapy for glaucoma.
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